BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3647909)

  • 1. A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella.
    Phipps D; Menger M; Chadwick JS; Aston WP
    Dev Comp Immunol; 1987; 11(1):37-46. PubMed ID: 3647909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
    Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
    Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of recombinant cobra venom factor.
    Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
    J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
    Hew BE; Pangburn MK; Vogel CW; Fritzinger DC
    Toxicon; 2020 Sep; 184():68-77. PubMed ID: 32526239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.
    Smith CA; Vogel CW; Müller-Eberhard HJ
    J Biol Chem; 1982 Sep; 257(17):9879-82. PubMed ID: 6921201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time and dose studies of the effect of cobra venom factor on the in vivo immune response in Galleria mellonella to Pseudomonas aeruginosa.
    Aston WP; Chadwick JS
    Dev Comp Immunol; 1978 Jul; 2(3):425-33. PubMed ID: 99334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant cobra venom factor.
    Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
    Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
    Fritzinger DC; Hew BE; Thorne M; Pangburn MK; Janssen BJ; Gros P; Vogel CW
    Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
    Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
    Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cane sugar factor as an inducing agent of immunity in Galleria mellonella.
    Pryce MJ; Aston WP; Chadwick JS
    Dev Comp Immunol; 1990; 14(4):369-78. PubMed ID: 2128279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine modification impairs the C5-cleavage function of cobra venom factor-dependent C3/C5 convertase.
    Fu Q; McPhie P; Gowda DC
    Biochem Mol Biol Int; 1998 Jun; 45(1):133-44. PubMed ID: 9635137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FUT-175 as a potent inhibitor of C5/C3 convertase activity for production of C5a and C3a.
    Inagi R; Miyata T; Maeda K; Sugiyama S; Miyama A; Nakashima I
    Immunol Lett; 1991 Jan; 27(1):49-52. PubMed ID: 2019419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor D of the alternative pathway of bovine complement: isolation and characterization.
    Menger M; Aston WP
    Vet Immunol Immunopathol; 1984 Oct; 7(3-4):325-36. PubMed ID: 6568787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb.
    Krishnan V; Ponnuraj K; Xu Y; Macon K; Volanakis JE; Narayana SV
    Structure; 2009 Apr; 17(4):611-9. PubMed ID: 19368894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage.
    von Zabern I; Hinsch B; Przyklenk H; Schmidt G; Vogt W
    Immunobiology; 1980 Dec; 157(4-5):499-514. PubMed ID: 6905795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate.
    Vogel CW; Müller-Eberhard HJ
    J Biol Chem; 1982 Jul; 257(14):8292-9. PubMed ID: 6919543
    [No Abstract]   [Full Text] [Related]  

  • 17. Further studies on the effect and role of cobra venom factor on protective immunity in Galleria mellonella: activity in the response against Proteus mirabilis.
    Chadwick JS; Aston WP; Ricketson JR
    Dev Comp Immunol; 1980; 4(2):223-31. PubMed ID: 6995190
    [No Abstract]   [Full Text] [Related]  

  • 18. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity.
    Englberger W; Hadding U; Etschenberg E; Graf E; Leyck S; Winkelmann J; Parnham MJ
    Int J Immunopharmacol; 1988; 10(6):729-37. PubMed ID: 3198307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro generation of an antibacterial activity from the fat body and hemolymph of non-immunized larvae of Galleria mellonella.
    De Verno PJ; Chadwick JS; Aston WP; Dunphy GB
    Dev Comp Immunol; 1984; 8(3):537-46. PubMed ID: 6437887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of purified cobra venom factor, isolated from the venom of Naja naja atra, on the in vivo immune response in Galleria mellonella.
    Aston WP; Chadwick JS
    Dev Comp Immunol; 1981; 5(2):353-6. PubMed ID: 6786928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.